skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Fibroblast growth factor 21 attenuates hypoxia-induced pulmonary hypertension by upregulating PPARγ expression and suppressing inflammatory cytokine levels

Journal Article · · Biochemical and Biophysical Research Communications
;  [1];  [2]; ;  [1];
  1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Zhejiang, 325000 (China)
  2. Department of Respiratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Shanxi, 710061 (China)

Highlights: • FGF21 Attenuates Hypoxia-induced Pulmonary Hypertension as a Potential drug. • FGF21 may Inhibit Vascular Remodeling Through Suppressing PASMCs Proliferation. • FGF21 Upregulates PPARγ Expression and Inhibits Inflammatory Cytokines. Hypoxia-induced pulmonary hypertension (HPH) is a progressive disease characterized by a sustained, elevated pulmonary arterial pressure and vascular remodeling. The latter pathogenesis mainly involves overproliferation of pulmonary artery smooth muscle cells (PASMCs). Fibroblast growth factor 21 (FGF21) has recently emerged as a novel regulator that prevents cardiac hypertrophic remodeling. However, its possible role in pulmonary remodeling remains unclear. The activation of peroxisome proliferator activated receptor γ (PPARγ) is reported to attenuate HPH by suppressing proliferative signals. Loss of PPARγ in the lung contributes to abnormal proliferation of PASMCs. FGF21 is a key regulator of PPARγ activity in adipocytes, but its role has not been elucidated in PASMCs. Therefore, we hypothesized that FGF21 may confer therapeutic effects in HPH by upregulating the expression of PPARγ. Sprague-Dawley rats were exposed to hypoxia and treated with FGF21 for 4 weeks. In parallel, hypoxic conditions and FGF21 were administered to rat PASMCs for 48 h. FGF21 attenuated the hypoxia-induced elevation in mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy (RVH), medial thickening and overproliferation of PASMCs. Furthermore, FGF21 abrogated the reductions in PPARγ expression and increases in TNF-α, IL-1 and IL-6 levels in PASMC culture media. Collectively, these results demonstrate that FGF21 could potentially attenuate the pathogenic derangements of HPH by targeting PPARγ and inflammatory cytokines.

OSTI ID:
23134199
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 504, Issue 2; Other Information: Copyright (c) 2018 Published by Elsevier Inc.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Suppression of Akt1 phosphorylation by adenoviral transfer of the PTEN gene inhibits hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells
Journal Article · Fri Jul 02 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:23134199

Negative feedback regulation between microRNA let-7g and LOX-1 mediated hypoxia-induced PASMCs proliferation
Journal Article · Sat Jul 08 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:23134199

Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway
Journal Article · Sun Nov 15 00:00:00 EST 2015 · Experimental Cell Research · OSTI ID:23134199